Citations

Clear

1444 citation(s) found for "Petersen, Ronald".

O4‐01‐01: Classification of MCI and Alzheimer's disease from CSF biomarkers: An ADNI study of Aß, tau and P‐tau versus 83 proteomic analytes
Yan, Jingwen , Shaw, Leslie M. , Trojanowski, John Q. , Aisen, Paul, Petersen, Ronald C. , Weiner, Michael W. , Li, Taiyong , Kim, Sungeun , Swaminathan, Shanker , Risacher, Shannon L. , Saykin, Andrew J. , Shen, Li

Mayo Clinic

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_17 | Pages: No page available

10.1016/j.jalz.2012.05.1634 Get It

P3‐271: Automated index of semantic verbal fluency in mild cognitive impairment and Alzheimer's disease
Pakhomov, Serguei , Hemmy, Laura S. , Kuskowski, Michael A., Roberts, Rosebud O., Petersen, Ronald C. , Boeve, Bradley F. , Knopman, David S.

Mayo Clinic

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_15 | Pages: No page available

10.1016/j.jalz.2012.05.1494 Get It

IC‐P‐014: Infarctions on antemortem MRI are associated with the presence of microinfarcts at autopsy
Raman, Mekala R., Preboske, Gregory M., Przybelski, Scott A. , Senjem, Matthew L. , Murphy, Matthew C. , Petersen, Ronald C. , Parisi, Joseph E. , Murray, Melissa E. , Boeve, Bradley F. , Knopman, David S. , Dickson, Dennis W. , Jack, Clifford R. , Kantarci, Kejal , Senjem, Matthew L

Mayo Clinic

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_1 | Pages: No page available

10.1016/j.jalz.2012.05.046 Get It

IC‐P‐109: Nonstationarity in the modular architecture of the “resting brain”
Jones, David, Murphy, Matthew C. , Gunter, Jeffrey L. , Senjem, Matthew L. , Przybelski, Scott A. , Gregg, Brian E., Petersen, Ronald C. , Jones, David, Vemuri, Prashanthi , Machulda, Mary M. , Kantarci, Kejal , Knopman, David S. , Boeve, Bradley F. , Jack, Clifford R. , Senjem, Matthew L

Mayo Clinic

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_2 | Pages: No page available

10.1016/j.jalz.2012.05.143 Get It

O4‐04‐04: NIA‐AA MCI criteria applied to the Mayo Clinic Study of Aging
Petersen, Ronald, Wiste, Heather J. , Weigand, Stephen D. , Lowe, Val J. , Gunter, Jeffrey L. , Ivnik, Robert J., Boeve, Bradley, Roberts, Rosebud O., Knopman, David S. , Jack, Clifford R. , Vemuri, Prashanthi , Kantarci, Kejal , Senjem, Matthew L. , Mielke, Michelle M.

Mayo Clinic

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_17 | Pages: No page available

10.1016/j.jalz.2012.05.1655 Get It

P1‐173: A kindred with familial frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72
Wicklund, Meredith, Daube, Jasper R., DeJesus‐Hernandez, Mariely, Parisi, Joseph E. , Josephs, Keith A. , Kuntz, Karen M. , Johnson, Kris , Ivnik, Robert J., Petersen, Ronald C. , Rademachers, Rosa, Boeve, Bradley F. , Dickson, Dennis W. , Baker, Matthew , Knopman, David S.

Mayo Clinic

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_5 | Pages: No page available

10.1016/j.jalz.2012.05.451 Get It

The epidemiology of Alzheimer's disease: Laying the foundation for drug design, conduct, and analysis of clinical trials
Yaffe, Kristine , Tocco, Michael , Petersen, Ronald C. , Sigler, Catherine , Burns, Leah , Cornelius, Christel, Khachaturian, Ara S. , Irizarry, Michael C. , Carrillo, María C.

Mayo Clinic

Alzheimer's & Dementia | July 3, 2012 | Volume: 8 | Issue: 3 | Pages: 237-242

10.1016/j.jalz.2011.12.005 | PMID 22546356 Get It

AbstractEpidemiological studies increasingly inform Alzheimer's disease (AD) public health impact, prevention strategies, drug targets, therapeutic interventions, and clinical trial design. For this reason, the Alzheimer's Association Research Roundtable convened an international group of AD experts with experience in conducting both observational and clinical trials for a meeting on October 19 and 20, 2010, in Washington, DC, to discuss the role of epidemiologic studies in AD research and therapeutic advances. Topics included wellness markers and risk factors, with a focus on special populations such as those at elevated risk, super agers, and underserved populations. Discussions also highlighted lessons learned from observational studies of aging, cardiovascular disease, and other disease areas, as well as how new technologies have enabled the gathering of data relevant to drug development and clinical trial conduct.
Conversion
Petersen, Ronald C.

Mayo Clinic

Neurology | May 13, 2012 | Volume: 67 | Issue: 9_suppl_3 | Pages: No page available

10.1212/wnl.67.9_suppl_3.s12 | PMID 17101927 Get It